Advancing Biomedical Science through Tissue Arrays |
| Home >> Welcome to Pantomics Price List Download |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Dedicated facility |
Catalog# MTU951 - 40 types of human tumor tissue array
| Lot# | Cores | Size | Cut | Format | QA/QC | Price 1Slide |
Price Pack5 |
| MTU95101 | 95 | 1.5mm | 4um | 8X12 | H&E, IHC anti-Vimentin/Cytokeratin | $150 | $600 |
|
Order:
sales@pantomics.com
or call
1-415-863-2380,
Form:
Word
or
PDF;
PDF data |
|||||||
|
Recommended applications:
For Research use only. RNA or protein general tumor tissue profiling using IHC or ISH;
Antibody characterization. Description: 40 tumor types, covering most of the common benign, malignant and metastatic tumors originated from 27 anatomic sites. Majority of the tumors have duplicates or triplicates from different individuals with corresponding uninvolved tissues as controls. Most of the tissues were from surgical resection. Those highlighted by '*" were from autopsy. All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention. |
 |
|
Array |
Sex |
Age |
Anatomic |
Histology |
Grade |
Stage (TNM) |
|
A01 |
F |
37 |
Adrenal gland |
Normal |
|
|
|
A02 |
M |
61 |
Adrenal gland |
Cortical adenoma |
|
|
|
A03 |
M |
28 |
Adrenal gland |
Cortical carcinoma |
|
|
|
A04 |
M |
53 |
Bladder |
Normal |
|
|
|
A05 |
F |
53 |
Bladder |
Transitional cell carcinoma |
II |
T1N0M0 |
|
A06 |
F |
65 |
Bladder |
Transitional cell carcinoma |
I~II |
T1N0M0 |
|
A07 |
F |
30 |
Breast |
Normal |
|
|
|
A08 |
F |
40 |
Breast |
Adenoma |
|
|
|
A09 |
F |
39 |
Breast |
Adenoma |
|
|
|
A10 |
F |
58 |
Breast |
Adenocarcinoma |
II |
T2N1M0 |
|
A11 |
F |
53 |
Breast |
Adenocarcinoma |
II |
T2N0M0 |
|
A12 |
F |
42 |
Breast |
Adenocarcinoma |
II |
T4N1M0 |
|
B01 |
M |
17 |
Bone |
Chondrosarcoma |
|
|
|
B02 |
M |
44 |
Bone |
Chondrosarcoma |
|
|
|
B03 |
M |
49 |
Cerebellum |
Normal |
|
|
|
B04 |
F |
65 |
Cerebellum |
Meningioma |
I~II |
|
|
B05 |
M |
55 |
Cerebellum |
Malignant meningioma |
III |
|
|
B06 |
M |
58 |
Cerebra (brain) |
Normal |
|
|
|
B07 |
F |
26 |
Cerebra (brain) |
Meningioma |
I~II |
|
|
B08 |
M |
47 |
Cerebra (brain) |
Astrocytoma |
II |
|
|
B09 |
M |
53 |
Esophagus |
Normal |
|
|
|
B10 |
F |
68 |
Esophagus |
Squamous cell carcinoma |
I |
T2N0M0 |
|
B11 |
M |
54 |
Esophagus |
Squamous cell carcinoma |
II |
T2N1M0 |
|
B12 |
F |
61 |
Esophagus |
Squamous cell carcinoma |
III |
T2N1M0 |
|
C01 |
M |
59 |
Stomach |
Normal |
|
|
|
C02 |
M |
52 |
Stomach |
Adenocarcinoma |
I |
T2N0M0 |
|
C03 |
M |
66 |
Stomach |
Signet ring cell carcinoma |
|
T3N0M0 |
|
C04 |
M |
47 |
Stomach |
Adenocarcinoma |
II |
T3N2M0 |
|
C05 |
F |
40 |
Small intestine |
Normal |
|
|
|
C06 |
F |
18 |
Small intestine |
Adenoma |
|
|
|
C07 |
F |
57 |
Small intestine |
Adenocarcinoma |
II |
T2N0M0 |
|
C08 |
F |
27 |
Colon |
Normal |
|
|
|
C09 |
M |
57 |
Colon |
Adenoma |
|
|
|
C10 |
M |
56 |
Colon |
Adenocarcinoma |
I |
T3N0M0 |
|
C11 |
M |
89 |
Colon |
Adenocarcinoma |
II |
T2N0M0 |
|
C12 |
F |
43 |
Colon |
Adenocarcinoma |
III |
T3N0M0 |
|
D01 |
M |
61 |
Rectum |
Normal |
|
|
|
D02 |
M |
40 |
Rectum |
Adenocarcinoma |
I |
T3N0M0 |
|
D03 |
M |
38 |
Rectum |
Adenocarcinoma |
II |
T3N1M0 |
|
D04 |
M |
50 |
Rectum |
Adenocarcinoma |
III |
T3N1M0 |
|
D05 |
F |
51 |
Kidney |
Normalcortex |
|
|
|
D06 |
M |
40 |
Kidney |
Clear cell carcinoma |
|
T1N0M0 |
|
D07 |
F |
79 |
Kidney |
Clear cell carcinoma |
|
T1N0M0 |
|
D08 |
M |
43 |
Liver |
Normal |
|
|
|
D09 |
M |
26 |
Liver |
Hepatocellular carcinoma |
I |
T2N0M0 |
|
D10 |
M |
40 |
Liver |
Hepatocellular carcinoma |
II |
T2N0M0 |
|
D11 |
M |
53 |
Liver |
Hepatocellular carcinoma |
I |
T2N0M0 |
|
D12 |
M |
41 |
Liver |
Hepatocellular carcinoma |
III |
T2N0M0 |
|
E01 |
M |
58 |
Lung |
Normal |
|
|
|
E02 |
M |
59 |
Lung |
Squamous cell carcinoma |
II |
T2N2M0 |
|
E03 |
M |
62 |
Lung |
Squamous cell carcinoma |
II~III |
T2N0M0 |
|
E04 |
M |
72 |
Lung |
Adenocarcinoma |
III |
T2N2M0 |
|
E05 |
M |
19 |
Lung |
Small cell carcinoma |
|
T3N0M0 |
|
E06 |
F |
39 |
Lymph node |
Reactive |
|
|
|
E07 |
M |
50 |
Lymph node |
Hodgkin's |
|
|
|
E08 |
M |
42 |
Lymph node |
B-NHL |
|
|
|
E09 |
M |
51 |
Lymph node |
T-NHL |
|
|
|
E10 |
F |
48 |
Oranasopharynx |
Hard palate adenocarcinoma |
III~IV |
|
|
E11 |
M |
56 |
Oranasopharynx |
Tongue Squamous cell carcinoma |
II |
T2N0M0 |
|
E12 |
F |
48 |
Oranasopharynx |
NPC |
III |
T2N0M0 |
|
F01 |
F |
45 |
Ovary |
Normal |
|
|
|
F02 |
F |
55 |
Ovary |
Adenoma |
|
|
|
F03 |
F |
45 |
Ovary |
Adenocarcinoma |
III |
T2N0M0 |
|
F04 |
F |
49 |
Ovary |
Adenocarcinoma |
III |
T1N0M0 |
|
F05 |
M |
35 |
Pancreas |
Normal |
|
|
|
F06 |
F |
49 |
Pancreas |
Adenocarcinoma |
II |
T3N1M1 |
|
F07 |
M |
65 |
Prostate |
Normal |
|
|
|
F08 |
M |
60 |
Prostate |
Adenocarcinoma |
II |
T2N0M0 |
|
F09 |
M |
47 |
Prostate |
Adenocarcinoma |
III |
T2N0M0 |
|
F10 |
M |
38 |
Salivary gland |
Normal |
|
|
|
F11 |
F |
28 |
Salivary gland |
Pleomorphic adenoma |
|
|
|
F12 |
F |
38 |
Salivary gland |
Adenocarcinoma |
I~II |
T1N0M0 |
|
G01 |
M |
50 |
Skin |
Normal |
|
|
|
G02 |
M |
67 |
Skin |
Squamous cell carcinoma |
II |
T2N0M0 |
|
G03 |
M |
53 |
Skin |
melanoma |
|
|
|
G04 |
M |
77 |
Testis |
Normal |
|
|
|
G05 |
M |
30 |
Testis |
Seminoma |
|
|
|
G06 |
M |
28 |
Testis |
Seminoma |
|
|
|
G07 |
F |
62 |
Thyroid |
Normal |
|
|
|
G08 |
F |
47 |
Thyroid |
Adenoma |
|
|
|
G09 |
F |
27 |
Thyroid |
Adenoma |
|
|
|
G10 |
F |
66 |
Thyroid |
Adenoma |
|
|
|
G11 |
M |
16 |
Thyroid |
Adenocarcinoma |
II~III |
T3N1M0 |
|
G12 |
M |
34 |
Thyroid |
Adenocarcinoma |
II |
T2N1M0 |
|
H01 |
F |
41 |
Uterus-cervix |
Normal |
|
|
|
H02 |
F |
63 |
Uterus-cervix |
Squamous cell carcinoma |
III |
T1N0M0 |
|
H03 |
F |
57 |
Uterus-cervix |
Squamous cell carcinoma |
III |
T1N1M0 |
|
H04 |
F |
50 |
Uterus-endometrium |
Normal |
|
|
|
H05 |
F |
48 |
Uterus-endometrium |
Adenocarcinoma |
I-II |
T2N0M0 |
|
H06 |
F |
53 |
Uterus-endometrium |
Adenocarcinoma |
II~III |
T1N1M0 |
|
H07 |
M |
60 |
Liver |
Metastatic cancers derived from colon carcinoma |
|
|
|
H08 |
M |
69 |
Lung |
Metastatic cancers derived from gastric carcinoma |
|
|
|
H09 |
F |
34 |
Lymph node |
Metastatic cancers derived from breast carcinoma |
|
|
|
H10 |
F |
40 |
Ovary |
Metastatic cancers derived from colon carcinoma |
|
|
|
H11 |
M |
51 |
Lymph node |
Metastatic cancers derived from squamous cell carcinoma |
|
|
-------------------------------------------------------------------------------------------------
All Products
|
Ordering Information
|
Privacy Policy
Copyright © 2004-2005,
Pantomics, Inc.
457 Mariposa Street, San Francisco, CA
94107, USA.
Tel: 415-863-2380